Form 4: Myriad Genetics CEO Paul J. Diaz Reports Stock Transactions

Paul J. Diaz, President and CEO of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Summary

• Paul J. Diaz, the President and CEO of Myriad Genetics, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• The report indicates that shares of common stock were withheld by Myriad Genetics to satisfy tax withholding obligations related to the vesting of restricted stock units.
• On March 22, 2024, 20,202 shares were withheld at a price of $22.24, resulting in Mr. Diaz owning 1,339,832 shares.
• On March 24, 2024, an additional 18,589 shares were withheld at $22.24, leaving him with 1,321,243 shares.
• Also on March 24, 2024, 27,233 performance-based restricted stock units were withheld at $22.24, resulting in a total of 1,294,010 shares owned.
• All transactions were direct holdings.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions related to tax obligations, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard tax-related stock withholding, which is a common practice.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they relate to tax obligations of the CEO.

Key Dates